Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Zhaoyun, Liu"'
Autor:
Xinyu Guo, Wenyan Jin, Yuchen Wen, Zhiqin Wang, Xiaotong Ren, Zhaoyun Liu, Rong Fu, Zhigang Cai, Lijuan Li
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Myelodysplastic syndrome (MDS) is a complicated hematopoietic malignancy characterized by bone marrow (BM) dysplasia with symptoms like anemia, neutropenia, or thrombocytopenia. MDS exhibits considerable heterogeneity in prognosis
Externí odkaz:
https://doaj.org/article/c5c0e8f4b0e844d2a0ad9963d12ce26e
Autor:
Hui Liu, Wei Wang, Chaomeng Wang, Liyan Li, Junshu Wu, Yingying Chen, Zhaoyun Liu, Honglei Wang, Lijuan Li, Rong Fu
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 7, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/e629bcdff0984cb4bfe34ca4e3ab614f
Autor:
Zhe Luan, Fangfang Liu, Li Zhang, Jun Chen, Yiming Zhao, Congyong Li, Zhaoyun Liu, Huawei Li, Li Dong, Funing Zang, Lingyan Han, Tianyue Zhao, Qiao Wang, Gang Sun, Shufang Wang
Publikováno v:
Heliyon, Vol 10, Iss 13, Pp e33619- (2024)
Objectives: Effective exclusion of low-risk symptomatic outpatient cases for colorectal cancer (CRC) remains diagnostic challenges. We aimed to develop a self-reported symptom-based decision-making model for application in outpatient scenarios. Metho
Externí odkaz:
https://doaj.org/article/d359bd9d005043819d1cf3a006557e0a
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-22 (2024)
Abstract Cellular immunotherapy, particularly CAR-T cells, has shown potential in the improvement of outcomes in patients with refractory and recurrent malignancies of the blood. However, achieving sustainable long-term complete remission for blood c
Externí odkaz:
https://doaj.org/article/5f569494e79b4ac2850776d9e2d8a691
Autor:
Xin Xu, Wei Zhao, Cuicui Liu, Yongsheng Gao, Dawei Chen, Meng Wu, Chao Li, Xinzhao Wang, Xiang Song, Jinming Yu, Zhaoyun Liu, Zhiyong Yu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Purpose The residual cancer burden index (RCB) was proposed as a response evaluation criterion in breast cancer patients treated with Neoadjuvant Chemotherapy (NAC). This study evaluated the relevance of RCB with replase-free survival (RFS).
Externí odkaz:
https://doaj.org/article/188296e818df41ffb2b54b586bf031fb
Autor:
Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong Yu
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Background The pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) of breast cancer is closely related to a better prognosis. However, there are no reliable indicators to accurately identify which patients will achieve pCR
Externí odkaz:
https://doaj.org/article/42895d5278c34e57b74199c52f67e091
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-20 (2023)
Abstract Multiple myeloma (MM) is related to immune disorders, recent studys have revealed that immunotherapy can greatly benefit MM patients. Immune checkpoints can negatively modulate the immune system and are closely associated with immune escape.
Externí odkaz:
https://doaj.org/article/e26d2a7fd1424f14860253834bc5c362
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Although neoadjuvant trastuzumab and pertuzumab (HP)-based regimens are recommended for human epidermal receptor-positive (HER2 +)/lymph node-positive (N +) breast cancer (BC) patients according to NCCN guidelines, it is undeniabl
Externí odkaz:
https://doaj.org/article/840ca610c6ff4b6a8a32850a6bc79baf
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11746-11759 (2023)
Abstract Multiple myeloma (MM) is the second common hematologic malignancy manifesting as a clonal proliferation of plasma cells in the bone marrow. In recent years, high expression and activity of pim kinase have been found to be associated with bot
Externí odkaz:
https://doaj.org/article/718296f81ad54e1a983632cc0d1dd1ca
Autor:
Fukai Wang, Shuangshuang Ma, Panpan Chen, Yuhao Han, Zhaoyun Liu, Xinzhao Wang, Chenglong Sun, Zhiyong Yu
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Reprogrammed metabolic network is a key hallmark of cancer. Profiling cancer metabolic alterations with spatial signatures not only provides clues for understanding cancer biochemical heterogeneity, but also helps to decipher the
Externí odkaz:
https://doaj.org/article/b1233a6a6ba44f669e0a3a1a404b9cc5